Research location

Niška Banja

Serbia

Published trials73
Site observations74
Linked trials published73
Page1 / 2
Advertisement

Research activity in Niška Banja

Serbia

CureCurrent currently publishes aggregate city-level research activity for this location: 73 trials and 74 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Niška Banja

73 linked trials · page 1 of 2
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseNCT07181109 · 2025-09-22 · 1 site observation
RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseNCT07064473 · 2025-07-22 · 1 site observation
RECRUITING
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartNCT06935370 · 2025-05-20 · 1 site observation
RECRUITING
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart FailureNCT06424288 · 2024-06-17 · 1 site observation
RECRUITING
CRF2 Agonist for the Treatment of Worsening Heart FailureNCT06815471 · 2025-08-07 · 1 site observation
SUSPENDED
Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RANCT05460832 · 2022-08-29 · 1 site observation
COMPLETED
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)NCT04509674 · 2020-12-16 · 1 site observation
COMPLETED
MSB11456 in Participants With Moderately to Severely Active Rheumatoid ArthritisNCT04512001 · 2020-08-03 · 1 site observation
COMPLETED
A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid ArthritisNCT04230213 · 2020-01-13 · 1 site observation
COMPLETED
Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)NCT03888066 · 2019-04-24 · 1 site observation
COMPLETED
Phase IIb Study of Evobrutinib in Subjects With Rheumatoid ArthritisNCT03233230 · 2017-09-18 · 1 site observation
COMPLETED
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF PatientsNCT03066804 · 2017-08-22 · 1 site observation
COMPLETED
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid ArthritisNCT03025308 · 2017-02-28 · 1 site observation
COMPLETED
Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To MethotrexateNCT02969044 · 2016-12-20 · 1 site observation
COMPLETED
A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350NCT02983227 · 2016-11-30 · 1 site observation
COMPLETED
Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To MethotrexateNCT02996500 · 2016-11-10 · 1 site observation
COMPLETED
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)NCT02833350 · 2016-09-09 · 1 site observation
COMPLETED
Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateNCT02889796 · 2016-08-30 · 1 site observation
COMPLETED
Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis ParticipantsNCT02573012 · 2016-03-29 · 1 site observation
COMPLETED
Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid ArthritisNCT02640612 · 2016-01-22 · 1 site observation
COMPLETED
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CADNCT02586155 · 2015-11-01 · 1 site observation
COMPLETED
An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid ArthritisNCT02518620 · 2015-07-01 · 1 site observation
COMPLETED
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).NCT02480153 · 2015-06-25 · 1 site observation
COMPLETED
A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid ArthritisNCT02287922 · 2015-03-01 · 1 site observation
COMPLETED
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid ArthritisNCT02137226 · 2015-01-26 · 1 site observation
COMPLETED
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid ArthritisNCT02309359 · 2015-01-01 · 1 site observation
COMPLETED
A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).NCT02222493 · 2014-08-26 · 1 site observation
COMPLETED
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection FractionNCT01920711 · 2014-07-18 · 1 site observation
COMPLETED
Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) PatientsNCT02064868 · 2014-01-31 · 1 site observation
TERMINATED
Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid ArthritisNCT01999192 · 2013-10-01 · 1 site observation
TERMINATED
Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid ArthritisNCT01911234 · 2013-09-01 · 1 site observation
COMPLETED
Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003NCT01856309 · 2013-08-07 · 1 site observation
COMPLETED
MabionCD20® Compared to MabThera® in Patients With Rheumatoid ArthritisNCT02468791 · 2013-05-01 · 1 site observation
COMPLETED
A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid ArthritisNCT01715896 · 2013-03-01 · 1 site observation
COMPLETED
A Long Term Safety Study of Mavrilimumab in Adult Subjects With Rheumatoid ArthritisNCT01712399 · 2013-01-28 · 1 site observation
TERMINATED
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid ArthritisNCT01647451 · 2012-09-01 · 1 site observation
COMPLETED
A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)NCT01604343 · 2012-08-15 · 1 site observation
COMPLETED
A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid ArthritisNCT01706926 · 2012-08-01 · 1 site observation
COMPLETED
Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart FailureNCT01661634 · 2012-07-01 · 1 site observation
COMPLETED
A Non-Interventional Study Evaluating Rheumatoid Arthritis Participants Treated With Tocilizumab (RoActemra/Actemra)NCT01671059 · 2012-07-01 · 2 site observations
COMPLETED
24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking MethotrexateNCT01590459 · 2012-04-01 · 1 site observation
COMPLETED
Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid ArthritisNCT01393639 · 2011-09-27 · 1 site observation
COMPLETED
A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk FactorsNCT01331837 · 2011-08-02 · 1 site observation
COMPLETED
Essential HypertensionNCT01264692 · 2011-02-01 · 1 site observation
COMPLETED
Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)NCT01242514 · 2011-01-01 · 1 site observation
TERMINATED
An Epidemiological Study to Evaluate Standard Daily Practice in Managing Patients With Arterial HypertensionNCT01201980 · 2010-12-01 · 1 site observation
COMPLETED
Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding.NCT01197534 · 2010-09-01 · 1 site observation
COMPLETED
Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid ArthritisNCT01063803 · 2010-02-01 · 1 site observation
COMPLETED
A 12-week Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid ArthritisNCT01052194 · 2010-02-01 · 1 site observation
COMPLETED
Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid ArthritisNCT01008852 · 2009-12-01 · 1 site observation
COMPLETED
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.